PMI (Picard Medical) ROE % Adjusted to Book Value: 0.00% (As of Mar. 2026)


PMI Picard Medical Inc PMI
4 GF Score
Price $0.14
! 4 Warning Signs
View Full Analysis

What is Picard Medical ROE % Adjusted to Book Value?

Picard Medical PMI -10.93% 4 ROE % Adjusted to Book Value is 0.00% as of Mar. 2026. GuruFocus rates PMI with a GF Score™ of 4/100. The stock has 4 warning signs investors should review.

Picard Medical's ROE % for the quarter that ended in Mar. 2026 was -2,602.65%. Picard Medical's PB Ratio for the quarter that ended in Mar. 2026 was N/A. Picard Medical's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was N/A.

Picard Medical ROE % Adjusted to Book Value Related Terms

Picard Medical ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Picard Medical's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Picard Medical ROE % Adjusted to Book Value Chart

Picard Medical Annual Data
Trend Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
0.00 0.00 0.00 0.00

Picard Medical Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -8.51 0.00

PMI vs TRIB, NXL, CSDX: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, Picard Medical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Picard Medical ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Picard Medical's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Picard Medical's ROE % Adjusted to Book Value falls into.


PMI
4GF Score
Picard Medical Inc PMI
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Picard Medical ROE % Adjusted to Book Value Calculation

Picard Medical's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / 34.31
=0.00%

Picard Medical's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-2,602.65% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Picard Medical (PMI) has a ROE % Adjusted to Book Value of 0.00% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Picard Medical and its competitors.
Is Picard Medical's ROE % Adjusted to Book Value too high?
Picard Medical's current ROE % Adjusted to Book Value is 0.00%. Overall, Picard Medical has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Picard Medical's ROE % Adjusted to Book Value compare to TRIB and NXL?
Picard Medical's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Picard Medical and its competitors. Picard Medical's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Picard Medical stock overvalued right now?
Picard Medical (PMI) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Picard Medical's overall GF Score™ is 4/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Picard Medical (PMI), the current ROE % Adjusted to Book Value is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Picard Medical Business Description

Address 1992 East Silverlake, Tucson, AZ, USA, 85713
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.
4GF Score

Get the complete analysis for PMI

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.14
Price